Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Afadin is a scaffold protein repressing insulin action via HDAC6 in adipose tissue

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Direct action of endocrine disrupting chemicals on human sperm

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson’s Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Authors’ response: Association between IBD and Parkinson’s disease: seek and you shall find?

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Authors' response: Association between IBD and Parkinson's disease: seek and you shall find?

    Publikation: Bidrag til tidsskriftKommentar/debatForskning

  4. Impaired Wnt Signaling in the Prefrontal Cortex of Alzheimer's Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Aggregation of α-synuclein is a hallmark of Parkinson's disease and dementia with Lewy bodies. We here investigate the relationship between cytosolic Ca2+and α-synuclein aggregation. Analyses of cell lines and primary culture models of α-synuclein cytopathology reveal an early phase with reduced cytosolic Ca2+levels followed by a later Ca2+increase. Aggregated but not monomeric α-synuclein binds to and activates SERCAin vitro, and proximity ligation assays confirm this interaction in cells. The SERCA inhibitor cyclopiazonic acid (CPA) normalises both the initial reduction and the later increase in cytosolic Ca2+CPA protects the cells against α-synuclein-aggregate stress and improves viability in cell models and inCaenorhabditis elegans in vivoProximity ligation assays also reveal an increased interaction between α-synuclein aggregates and SERCA in human brains affected by dementia with Lewy bodies. We conclude that α-synuclein aggregates bind SERCA and stimulate its activity. Reducing SERCA activity is neuroprotective, indicating that SERCA and down-stream processes may be therapeutic targets for treating α-synucleinopathies.

OriginalsprogEngelsk
TidsskriftEMBO Reports
ISSN1469-221X
DOI
StatusUdgivet - 1 maj 2018

ID: 53547142